Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Gastric cancer burden in Northern Central America demands regional control plans

Northern Central America carries a heavy gastric cancer burden, with low survival and limited registry data driving calls for practical prevention strategies.

By Dr. Revathy Mohan V.R., MBBS · Oct 27, 2026 · 5 min read

Oncology·Lancet Onc

ADT-Induced Vasomotor Symptoms in Prostate Cancer Disrupt Quality of Life

Systematic review finds ADT-related hot flashes and night sweats in prostate cancer are tied more to symptom severity…

Oct 27, 2026

Oncology·Becker H

Molecular Residual Disease Testing Needs Scale, but Source Lacks Detail

Only the headline was available, so a publication-grade rewrite would require additional source text to avoid inventing endpoints…

Oct 27, 2026

Oncology·NIH

CD20 CAR T-Cell Therapy Shows Durable Responses in Relapsed B-NHL

Phase I MB-CART20.1 data show manageable toxicity, CAR T expansion, and durable complete responses in relapsed or refractory…

Oct 27, 2026

Oncology·NIH

Multiple Myeloma Study Examines Patient-Reported Outcomes and Skeletal Symptoms

A prospective cohort study in multiple myeloma evaluates patient-reported outcomes and skeletal symptoms across proteasome inhibitor-based therapy.

Oct 27, 2026

Oncology·NIH

Advanced RCC: LITESPARK-012 Finds No Gain From Belzutifan or Quavonlimab

LITESPARK-012 found no PFS or survival advantage from adding belzutifan or quavonlimab to pembrolizumab plus lenvatinib in advanced…

Oct 27, 2026

Oncology·Nature

CD44v6 and PI3K Blockade Counters Colorectal Cancer Stem Cell Reprogramming

AMC303 plus Apitolisib curtailed HGF-driven colorectal cancer stem cell reprogramming and resistance by blocking compensatory PI3K, AKT, and…

Oct 27, 2026

Oncology·ACC-PRO

BioNTech breast cancer ADC shows modest PFS gain with ILD signal

BioNTech’s phase 3 breast cancer ADC trial showed modest progression-free survival benefit but more ILD, clouding its competitive…

Oct 27, 2026

Oncology·BBC Dental

Pope Leo to keep South American tour after lung cancer surgery

The Vatican says Pope Leo will continue his South American tour after lung cancer surgery and a localized…

Oct 27, 2026

Oncology·BBC Dental

Enhertu access denied for woman on third chemotherapy line in NHS England

A woman with secondary breast cancer says NHS rules block Enhertu after a third chemotherapy line, despite hopes…

Oct 27, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.